What is the role for adjuvant radiation therapy in advanced Hodgkin's disease?
P Mauch
JCO Mar 1 1998: 815–817. [PDF]
	Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group
	M Loeffler, O Brosteanu, D Hasenclever, M Sextro, D Assouline, AA Bartolucci, PA Cassileth, D Crowther, V Diehl, RI Fisher, RT Hoppe, P Jacobs, JL Pater, S Pavlovsky, E Thompson, and P Wiernik
	JCO Mar 1 1998: 818–829. [Abstract] [PDF]
	Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group
	L Specht, RG Gray, MJ Clarke, and R Peto
	JCO Mar 1 1998: 830–843. [Abstract] [PDF]
	Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma
	JM Vose, PJ Bierman, JC Lynch, DD Weisenburger, A Kessinger, WC Chan, TC Greiner, and JO Armitage
	JCO Mar 1 1998: 844–849. [Abstract] [PDF]
	Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma
	DC Betticher, A von Rohr, D Ratschiller, SF Schmitz, T Egger, T Sonderegger, R Herrmann, T Kroner, GB Zulian, F Cavalli, MF Fey, and T Cerny
	JCO Mar 1 1998: 850–858. [Abstract] [PDF]
	Long-term survival in primary CNS lymphoma
	LE Abrey, LM DeAngelis, and J Yahalom
	JCO Mar 1 1998: 859–863. [Abstract] [PDF]
	High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series
	JY Blay, T Conroy, C Chevreau, A Thyss, N Quesnel, H Eghbali, R Bouabdallah, B Coiffier, JP Wagner, A Le Mevel, D Dramais-Marcel, E Baumelou, F Chauvin, and P Biron
	JCO Mar 1 1998: 864–871. [Abstract] [PDF]
	Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group
	B Lowenberg, S Suciu, E Archimbaud, H Haak, P Stryckmans, R de Cataldo, AW Dekker, ZN Berneman, A Thyss, J van der Lelie, P Sonneveld, G Visani, G Fillet, M Hayat, A Hagemeijer, G Solbu, and R Zittoun
	JCO Mar 1 1998: 872–881. [Abstract] [PDF]
	Early treatment decisions with interferon-alfa therapy in early chronic- phase chronic myelogenous leukemia
	S Sacchi, HM Kantarjian, TL Smith, S O'Brien, S Pierce, S Kornblau, M Beran, MJ Keating, and M Talpaz
	JCO Mar 1 1998: 882–889. [Abstract] [PDF]
	Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group Study
	SE Salmon, JJ Crowley, SP Balcerzak, RW Roach, SA Taylor, SE Rivkin, and W Samlowski
	JCO Mar 1 1998: 890–896. [Abstract] [PDF]
	MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial
	RJ Hutchinson, CJ Fryer, PC Davis, J Nachman, MD Krailo, RT O'Brien, RD Collins, T Whalen, D Reardon, ME Trigg, and GS Gilchrist
	JCO Mar 1 1998: 897–906. [Abstract] [PDF]
	In vitro cytotoxicity of docetaxel in childhood acute leukemias
	R Consolini, CH Pui, FG Behm, SC Raimondi, and D Campana
	JCO Mar 1 1998: 907–913. [Abstract] [PDF]
	Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group
	EL Sievers, BJ Lange, PM Sondel, MD Krailo, J Gan, W Liu-Mares, and SA Feig
	JCO Mar 1 1998: 914–919. [Abstract] [PDF]
	Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group
	J Nachman, HN Sather, JM Cherlow, MG Sensel, PS Gaynon, JN Lukens, L Wolff, and ME Trigg
	JCO Mar 1 1998: 920–930. [Abstract] [PDF]
	Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia
	DI Marks, JM Bird, JM Cornish, NJ Goulden, CG Jones, CJ Knechtli, DH Pamphilon, CG Steward, and A Oakhill
	JCO Mar 1 1998: 931–936. [Abstract] [PDF]
	Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors
	MF Ozkaynak, K Matthay, M Cairo, RE Harris, S Feig, CP Reynolds, J Buckley, JG Villablanca, and RC Seeger
	JCO Mar 1 1998: 937–944. [Abstract] [PDF]
	Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study
	RL Saylors, 3rd, CF Stewart, WC Zamboni, DA Wall, B Bell, KC Stine, and TJ Vietti
	JCO Mar 1 1998: 945–952. [Abstract] [PDF]
	Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry
	R Ladenstein, T Philip, C Lasset, O Hartmann, A Garaventa, R Pinkerton, J Michon, J Pritchard, T Klingebiel, B Kremens, A Pearson, C Coze, P Paolucci, D Frappaz, H Gadner, and F Chauvin
	JCO Mar 1 1998: 953–965. [Abstract] [PDF]
	Conduct of phase I trials in children with cancer
	M Smith, M Bernstein, WA Bleyer, JD Borsi, P Ho, IJ Lewis, A Pearson, F Pein, C Pratt, G Reaman, R Riccardi, N Seibel, R Trueworthy, R Ungerleider, G Vassal, and T Vietti
	JCO Mar 1 1998: 966–978. [Abstract] [PDF]
	Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1- positive or BRCA2-positive patients
	VR Grann, KS Panageas, W Whang, KH Antman, and AI Neugut
	JCO Mar 1 1998: 979–985. [Abstract] [PDF]
	Allogeneic peripheral-blood progenitor-cell transplantation for poor- risk patients with metastatic breast cancer
	NT Ueno, G Rondon, NQ Mirza, DK Geisler, P Anderlini, SA Giralt, BS Andersson, DF Claxton, JL Gajewski, IF Khouri, M Korbling, RC Mehra, D Przepiorka, Z Rahman, BI Samuels, K van Besien, GN Hortobagyi, and RE Champlin
	JCO Mar 1 1998: 986–993. [Abstract] [PDF]
	Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study
	CW Taylor, S Green, WS Dalton, S Martino, D Rector, JN Ingle, NJ Robert, GT Budd, JC Paradelo, RB Natale, JD Bearden, JA Mailliard, and CK Osborne
	JCO Mar 1 1998: 994–999. [Abstract] [PDF]
	High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma
	LJ Ayash, A Elias, J Ibrahim, G Schwartz, C Wheeler, E Reich, C Lynch, D Warren, C Shapiro, P Richardson, D Hurd, L Schnipper, E Frei, 3rd, and K Antman
	JCO Mar 1 1998: 1000–1007. [Abstract] [PDF]
	Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant
	MJ Laughlin, DS McGaughey, JR Crews, NJ Chao, D Rizzieri, M Ross, J Gockerman, C Cirrincione, D Berry, L Mills, P Defusco, S LeGrand, WP Peters, and JJ Vredenburgh
	JCO Mar 1 1998: 1008–1012. [Abstract] [PDF]
	Prognostic significance of cathepsins B and L in primary human breast cancer
	JA Foekens, J Kos, HA Peters, M Krasovec, MP Look, N Cimerman, ME Meijer-van Gelder, SC Henzen-Logmans, WL van Putten, and JG Klijn
	JCO Mar 1 1998: 1013–1021. [Abstract] [PDF]
	Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer
	JA Hayman, BE Hillner, JR Harris, and JC Weeks
	JCO Mar 1 1998: 1022–1029. [Abstract] [PDF]
	Improvement in the prognosis of breast cancer from 1965 to 1984
	MJ Edwards, JW Gamel, and EJ Feuer
	JCO Mar 1 1998: 1030–1035. [Abstract] [PDF]
	Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer
	JJ Grau, J Estape, J Fuster, X Filella, J Visa, J Teres, G Soler, S Albiol, JC Garcia-Valdecasas, L Grande, J Bombi, J Bordas, and F Alcobendas
	JCO Mar 1 1998: 1036–1039. [Abstract] [PDF]
	Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management
	F Gibril, JL Doppman, JC Reynolds, CC Chen, VE Sutliff, F Yu, J Serrano, DJ Venzon, and RT Jensen
	JCO Mar 1 1998: 1040–1053. [Abstract] [PDF]
	Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group
	D Schrijvers, J Johnson, U Jiminez, M Gore, P Kosmidis, H Szpirglas, K Robbins, J Oliveira, R Lewensohn, J Schuller, A Riviere, C Arvay, P Langecker, H Jacob, E Cvitkovic, and E Vokes
	JCO Mar 1 1998: 1054–1059. [Abstract] [PDF]
	Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung
	M Adachi, T Taki, C Huang, M Higashiyama, O Doi, T Tsuji, and M Miyake
	JCO Mar 1 1998: 1060–1067. [Abstract] [PDF]
	Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group
	S Kudoh, Y Fujiwara, Y Takada, H Yamamoto, A Kinoshita, Y Ariyoshi, K Furuse, and M Fukuoka
	JCO Mar 1 1998: 1068–1074. [Abstract] [PDF]
	Prospective investigation of positron emission tomography in lung nodules
	VJ Lowe, JW Fletcher, L Gobar, M Lawson, P Kirchner, P Valk, J Karis, K Hubner, D Delbeke, EV Heiberg, EF Patz, and RE Coleman
	JCO Mar 1 1998: 1075–1084. [Abstract] [PDF]
	Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer
	T Susini, F Baldi, CM Howard, A Baldi, G Taddei, D Massi, S Rapi, L Savino, G Massi, and A Giordano
	JCO Mar 1 1998: 1085–1093. [Abstract] [PDF]
	Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix
	M Morris, KR Brader, C Levenback, TW Burke, EN Atkinson, WR Scott, and DM Gershenson
	JCO Mar 1 1998: 1094–1098. [Abstract] [PDF]
	Extravesical tumor relapse in patients with superficial bladder tumors
	HW Herr
	JCO Mar 1 1998: 1099–1102. [Abstract] [PDF]
	Prognostic factors for survival of patients treated systemically for disseminated melanoma
	O Eton, SS Legha, TE Moon, AC Buzaid, NE Papadopoulos, C Plager, AM Burgess, AY Bedikian, S Ring, Q Dong, AB Glassman, CM Balch, and RS Benjamin
	JCO Mar 1 1998: 1103–1111. [Abstract] [PDF]
	Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
	L Welles, MW Saville, J Lietzau, JM Pluda, KM Wyvill, I Feuerstein, WD Figg, R Lush, J Odom, WH Wilson, MT Fajardo, RW Humphrey, E Feigal, D Tuck, SM Steinberg, S Broder, and R Yarchoan
	JCO Mar 1 1998: 1112–1121. [Abstract] [PDF]
	Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks
	LL Siu, AM Oza, EA Eisenhauer, PS Firby, JJ Thiessen, M Michael, N Wainman, J Manzo, R Feld, RA Goldberg, and MJ Moore
	JCO Mar 1 1998: 1122–1130. [Abstract] [PDF]
	Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors
	I Rafi, AV Boddy, JA Calvete, GA Taylor, DR Newell, NP Bailey, MJ Lind, M Green, J Hines, A Johnstone, N Clendeninn, and AH Calvert
	JCO Mar 1 1998: 1131–1141. [Abstract] [PDF]
	Phase I clinical and pharmacokinetic trial of penclomedine using a novel, two-stage trial design for patients with advanced malignancy
	J Berlin, JA Stewart, B Storer, KD Tutsch, RZ Arzoomanian, D Alberti, C Feierabend, K Simon, and G Wilding
	JCO Mar 1 1998: 1142–1149. [Abstract] [PDF]
	Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis
	ER Lawlor, JA Mathers, T Bainbridge, DE Horsman, A Kawai, JH Healey, AG Huvos, JA Bridge, M Ladanyi, and PH Sorensen
	JCO Mar 1 1998: 1150–1157. [Abstract] [PDF]
	Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease
	G Tallini, RA Ghossein, J Emanuel, J Gill, B Kinder, AB Dimich, J Costa, R Robbins, GN Burrow, and J Rosai
	JCO Mar 1 1998: 1158–1166. [Abstract] [PDF]
	Randomized, placebo-controlled, multicenter trial of granulocyte- macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research Group
	NJ Meropol, DE Wood, J Nemunaitis, NJ Petrelli, BJ Lipman, JM Agosti, and JB Whitmore
	JCO Mar 1 1998: 1167–1173. [Abstract] [PDF]
	Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group
	J Latreille, J Pater, D Johnston, F Laberge, D Stewart, J Rusthoven, P Hoskins, B Findlay, E McMurtrie, L Yelle, C Williams, D Walde, S Ernst, H Dhaliwal, D Warr, F Shepherd, D Mee, L Nishimura, D Osoba, and B Zee
	JCO Mar 1 1998: 1174–1178. [Abstract] [PDF]
	Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis
	EA Engels, J Lau, and M Barza
	JCO Mar 1 1998: 1179–1187. [Abstract] [PDF]
	Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3)
	MJ Hjermstad, PM Fayers, K Bjordal, and S Kaasa
	JCO Mar 1 1998: 1188–1196. [Abstract] [PDF]
	Role of the p16 tumor suppressor gene in cancer
	WH Liggett, Jr and D Sidransky
	JCO Mar 1 1998: 1197–1206. [Abstract] [PDF]
	Molecular abnormalities in lung cancer
	R Salgia and AT Skarin
	JCO Mar 1 1998: 1207–1217. [Abstract] [PDF]
	Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence- based review
	DJ Bloomfield
	JCO Mar 1 1998: 1218–1225. [Abstract] [PDF]
	Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback
	GP Browman, TE Newman, EA Mohide, ID Graham, MN Levine, KI Pritchard, WK Evans, JA Maroun, DI Hodson, MS Carey, and DH Cowan
	JCO Mar 1 1998: 1226–1231. [Abstract] [PDF]
Massive splenomegaly in hairy cell leukemia
MS Tallman, D Hakimian, and L Peterson
JCO Mar 1 1998: 1232–1233. [PDF]
Dimension in defining tumor response
R Chappell, SS Miranpuri, and MP Mehta
JCO Mar 1 1998: 1234. [PDF]
Should MOPP-ABVD alone be standard for childhood Hodgkin's?
LS Constine
JCO Mar 1 1998: 1235a. [PDF]
Early versus late irradiation in small-cell lung cancer
RM Auchter
JCO Mar 1 1998: 1235b–1237. [PDF]
Need randomized clinical trials, not litigation
DS Fischer
JCO Mar 1 1998: 1237–1238. [PDF]
Patient selection in high-dose trials of breast cancer
DR Adkins, RA Brown, and JF DiPersio
JCO Mar 1 1998: 1238–1239. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.